Marta Sobczak

1.1k total citations
22 papers, 887 citations indexed

About

Marta Sobczak is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Pharmacology. According to data from OpenAlex, Marta Sobczak has authored 22 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Marta Sobczak's work include Neuropeptides and Animal Physiology (11 papers), Gastrointestinal motility and disorders (5 papers) and Cannabis and Cannabinoid Research (5 papers). Marta Sobczak is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Gastrointestinal motility and disorders (5 papers) and Cannabis and Cannabinoid Research (5 papers). Marta Sobczak collaborates with scholars based in Poland, Germany and China. Marta Sobczak's co-authors include Jakub Fichna, Maciej Sałaga, Martin Storr, Hubert Zatorski, Chunqiu Chen, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Wanda M. Krajewska, Anna Mokrowiecka and Ewa Małecka‐Panas and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Marta Sobczak

22 papers receiving 868 citations

Peers

Countries citing papers authored by Marta Sobczak

Since Specialization

Citations

This map shows the geographic impact of Marta Sobczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Sobczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Sobczak more than expected).

Fields of papers citing papers by Marta Sobczak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Sobczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Sobczak. The network helps show where Marta Sobczak may publish in the future.

Co-authorship network of co-authors of Marta Sobczak

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Sobczak. A scholar is included among the top collaborators of Marta Sobczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Sobczak. Marta Sobczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Platelet Activity in the Pathophysiology of Inflammatory Bowel Diseases 2015 ·Current Drug Targets ·Chunqiu Chen, Yongyu Li, Zhen Yu, Zhanju Liu, Yanhong Shi, Urszula Lewandowska, Marta Sobczak, Jakub Fichna, Martin E. Kreis	14
2	Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms 2014 ·European Journal of Pharmacology ·Marta Sobczak, Gerta Cami‐Kobeci, Maciej Sałaga, Stephen M. Husbands, Jakub Fichna	27
3	Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: New potential treatment of abdominal pain associated with inflammatory bowel diseases 2014 ·Peptides ·Marta Sobczak, (unknown), (unknown), (unknown), Maciej Sałaga, Andrzej W. Lipkowski, Jakub Fichna	30
4	Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases 2014 ·Pharmacological Reports ·Marta Sobczak, Adam Fabisiak, Natalia Murawska, (unknown), (unknown), (unknown), (unknown), Hubert Zatorski, (unknown), Jakub Fichna	78
5	Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review 2014 ·Current Treatment Options in Oncology ·Maciej Sałaga, Hubert Zatorski, Marta Sobczak, Chunqiu Chen, Jakub Fichna	98
6	Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors 2014 ·Biochemical Pharmacology ·Maciej Sałaga, Prabhakar R. Polepally, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Marta Sobczak, Radzisław Kordek, Jordan K. Zjawiony, Wanda M. Krajewska, Jakub Fichna	29
7	Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH) 2014 ·Journal of Crohn s and Colitis ·Maciej Sałaga, Anna Mokrowiecka, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Emma Leishman, Marta Sobczak, Hubert Zatorski, Ewa Małecka‐Panas, Radzisław Kordek, Martin Storr, Wanda M. Krajewska, Heather B. Bradshaw, Jakub Fichna	86
8	Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases 2014 ·Pharmacological Reports ·Marta Sobczak, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Anna Mokrowiecka, Chunqiu Chen, Maciej Sałaga, Ewa Małecka‐Panas, Radzisław Kordek, Wanda M. Krajewska, Jakub Fichna	19
9	Novel Orally Available Salvinorin A Analog PR-38 Inhibits Gastrointestinal Motility and Reduces Abdominal Pain in Mouse Models Mimicking Irritable Bowel Syndrome 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Maciej Sałaga, Prabhakar R. Polepally, Marta Sobczak, (unknown), Wojciech Kamysz, Andrei Sibaev, Martin Storr, (unknown), Jordan K. Zjawiony, Jakub Fichna	35
10	Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea‐predominant IBS 2014 ·Neurogastroenterology & Motility ·Jakub Fichna, Marta Sobczak, Anna Mokrowiecka, Adam I. Cygankiewicz, Piotr K. Zakrzewski, Nicolas Cénac, Maciej Sałaga, Jean‐Pierre Timmermans, Nathalie Vergnolle, Ewa Małecka‐Panas, Wanda M. Krajewska, Martin Storr	17
11	Current overview of colitis-associated colorectal cancer 2014 ·Open Life Sciences ·Marta Sobczak, (unknown), Hubert Zatorski, Maciej Sałaga, Jakub Fichna	5
12	Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice 2014 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Maciej Sałaga, Urszula Lewandowska, Dorota Sosnowska, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Aleksandra Piechota-Polańczyk, Marta Sobczak, Paula Mosińska, Chunqiu Chen, Wanda M. Krajewska, Jakub Fichna	34
13	Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract 2013 ·Drug Discovery Today ·Maciej Sałaga, Marta Sobczak, Jakub Fichna	22
14	Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives 2013 ·Journal of Gastroenterology ·Marta Sobczak, Maciej Sałaga, Martin Storr, Jakub Fichna	157
15	Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study 2013 ·PLoS ONE ·Jakub Fichna, JodiAnne T. Wood, Malvina Papanastasiou, Subramanian K. Vadivel, Piotr Oprocha, Maciej Sałaga, Marta Sobczak, Anna Mokrowiecka, Adam I. Cygankiewicz, Piotr K. Zakrzewski, Ewa Małecka‐Panas, Wanda M. Krajewska, (unknown), Alexandros Makriyannis, Martin Storr	48
16	Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Marta Sobczak, Anna Mokrowiecka, Adam I. Cygankiewicz, Piotr K. Zakrzewski, Maciej Sałaga, Martin Storr, Radzisław Kordek, Ewa Małecka‐Panas, Wanda M. Krajewska, Jakub Fichna	28
17	Nociceptin / Orphanin FQ (NOP) Receptors as Novel Potential Target in the Treatment of Gastrointestinal Diseases 2013 ·Current Drug Targets ·Marta Sobczak, (unknown), Martin Storr, Jakub Fichna	21
18	Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration 2013 ·Bioorganic & Medicinal Chemistry Letters ·Jakub Fichna, (unknown), (unknown), Wojciech Kamysz, Renata Perlikowska, (unknown), Marta Sobczak, Maciej Sałaga, Géza Tóth, Anna Janecka, Chunqiu Chen, Jacek Olczak	14
19	Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract 2013 ·European Journal of Pharmaceutical Sciences ·Maciej Sałaga, Marta Sobczak, Jakub Fichna	30
20	Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides 2013 ·Neurogastroenterology & Motility ·Jakub Fichna, Maciej Sałaga, Jordyn Stuart, Dieter Saur, Marta Sobczak, Hubert Zatorski, Jean‐Pierre Timmermans, Heather B. Bradshaw, Kyunghye Ahn, Martin Storr	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact